<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rehab</journal-id><journal-title-group><journal-title xml:lang="ru">Реабилитология</journal-title><trans-title-group xml:lang="en"><trans-title>Journal of Medical Rehabilitation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2949-5873</issn><issn pub-type="epub">2949-5881</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17749/2949-5873/rehabil.2024.17</article-id><article-id custom-type="elpub" pub-id-type="custom">rehab-9</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW ARTICLES</subject></subj-group></article-categories><title-group><article-title>Реабилитация пациенток после хирургического лечения синдрома поликистозных яичников</article-title><trans-title-group xml:lang="en"><trans-title>Rehabilitation of patients after surgical treatment for polycystic ovary syndrome</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-3302-138X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зайцева</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Zaitseva</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Зайцева Ольга Андреевна</p><p>ул. Трубецкая, д. 8/2, Москва 119048</p></bio><bio xml:lang="en"><p>Olga A. Zaitseva</p><p>8/2 Trubetskaya Str., Moscow 119048</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7456-2386</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Cолопова</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Solopova</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Солопова Антонина Григорьевна, д.м.н., проф.</p><p>WoS ResearcherID: Q-1385-2015</p><p>Scopus Author ID: 6505479504</p><p>ул. Трубецкая, д. 8/2, Москва 119048</p></bio><bio xml:lang="en"><p>Antonina G. Solopova, Dr. Sci. Med., Prof.</p><p>WoS ResearcherID: Q-1385-2015</p><p>Scopus Author ID: 6505479504</p><p>8/2 Trubetskaya Str., Moscow 119048</p></bio><email xlink:type="simple">antoninasolopova@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное автономное образовательное учреждение высшего образования «Первый Московский государственный медицинский университет им. И.М. Сеченова» Министерства здравоохранения Российской Федерации (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>06</day><month>09</month><year>2024</year></pub-date><volume>2</volume><issue>1</issue><fpage>133</fpage><lpage>148</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Зайцева О.А., Cолопова А.Г., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Зайцева О.А., Cолопова А.Г.</copyright-holder><copyright-holder xml:lang="en">Zaitseva O.A., Solopova A.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rehabilitology.com/jour/article/view/9">https://www.rehabilitology.com/jour/article/view/9</self-uri><abstract><p>Одним из наиболее часто встречающихся гинекологических заболеваний является синдром поликистозных яичников (СПКЯ). Патологические состояния, к которым приводит данный синдром, требуют пристального внимания со стороны не только гинекологов, но и терапевтов, эндокринологов, онкологов, кардиологов, психологов. Репродуктивная функция женщин с СПКЯ и ассоциированное с ним бесплодие нуждаются в дальнейшем тщательном изучении. Наравне с этим необходима разработка мероприятий по коррекции и профилактике всех нарушений, вызываемых данной патологией. В статье отражены важность мультидисциплинарного комплексного подхода к ведению пациенток с СПКЯ, необходимость изучения и реализации реабилитационных средств, направленных на восстановление всех аспектов здоровья женщины, в т.ч. после оперативного лечения.</p></abstract><trans-abstract xml:lang="en"><p>One of the most common gynecologic diseases is polycystic ovary syndrome (PCOS). The pathologic conditions caused by this syndrome require careful attention from not only gynecologists, but also therapists, endocrinologists, oncologists, cardiologists, and psychologists. The reproductive function of women with PCOS and associated infertility needs further careful study. At the same time, it is necessary to develop measures for the correction and prevention of all disorders associated with this pathology. The article describes the importance of multidisciplinary, comprehensive approach to PCOS patients, the need to study and implement rehabilitation means aimed at restoring all aspects of women's health, including after surgical treatment.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>синдром поликистозных яичников</kwd><kwd>СПКЯ</kwd><kwd>реабилитация</kwd><kwd>хирургическое лечение</kwd></kwd-group><kwd-group xml:lang="en"><kwd>polycystic ovary syndrome</kwd><kwd>PCOS</kwd><kwd>rehabilitation</kwd><kwd>surgical treatment</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Синдром поликистозных яичников. Клинические рекомендации. 2021. URL: https://cr.minzdrav.gov.ru/recomend/258_2 (дата обращения 08.11.2023).</mixed-citation><mixed-citation xml:lang="en">Polycystic ovary syndrome. Clinical guidelines. 2021. Available at: https://cr.minzdrav.gov.ru/recomend/258_2 (in Russ.) (accessed 08.11.2023).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Сухих Г.Т., Серов В.Н. (ред.) Тактика врача акушера-гинеколога: практическое руководство. М.: ГЭОТАР-Медиа; 2020: 504 с.</mixed-citation><mixed-citation xml:lang="en">Sukhikh G.T., Serov V.N. (Eds.) Tactics of an obstetrician-gynecologist: a practical guide. Мoscow: GEOTAR-Media; 2020: 504 pp. (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Гришин И.И., Чирвон Т.Г., Огеде О.Р. Современные тенденции хирургического лечения бесплодия, ассоциированного с синдромом поликистозных яичников. Русский медицинский журнал. Мать и дитя. 2022; 5 (3): 209–14. https://doi.org/10.32364/2618-8430-2022-5-3-209-214.</mixed-citation><mixed-citation xml:lang="en">Grishin I.I., Chernov T.G., Oguede O.R. Current trends in surgical treatment for infertility associated with polycystic ovary syndrome. Russian Journal of Woman and Child Health. 2022; 5 (3): 209–14 (in Russ.). https://doi.org/10.32364/2618-8430-2022-5-3-209-214.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Teede H.J., Tay C.T., Laven J.J.E., et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol. 2023; 189 (2): G43–64. https://doi.org/10.1093/ejendo/lvad096.</mixed-citation><mixed-citation xml:lang="en">Teede H.J., Tay C.T., Laven J.J.E., et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol. 2023; 189 (2): G43–64. https://doi.org/10.1093/ejendo/lvad096.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Андреева Е.Н., Шереметьева Е.В., Аракелян А.С. Хирургические аспекты лечения синдрома поликистозных яичников. Проблемы репродукции. 2020; 26 (5): 65–71. https://doi.org/10.17116/repro20202605165.</mixed-citation><mixed-citation xml:lang="en">Andreeva E.N., Sheremetyeva E.V., Arakelyan A.S. Surgical aspects of treating polycystic ovary syndrome. Russian Journal of Human Reproduction. 2020; 26 (5): 65–71 (in Russ.). https://doi.org/10.17116/repro20202605165.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Краснопольская К.В., Соколова Е.А., Ершова И.Ю., Исакова К.М. Восстановление фертильности при хирургическом лечении больных с бесплодием и синдромом поликистозных яичников в зависимости от длительности менструального цикла и фенотипа синдрома. Российский вестник акушера-гинеколога. 2020; 20 (4): 88–94. https://doi.org/10.17116/rosakush20202004188.</mixed-citation><mixed-citation xml:lang="en">Krasnopol’skaya K.V., Sokolova E.A., Ershova I.Yu., Isakova K.M. Recovery of fertility in the surgical treatment of patients with infertility and polycystic ovary syndrome, depending on the duration of the menstrual cycle and the phenotype of the syndrome. Russian Bulletin of Obstetrician-Gynecologist. 2020; 20 (4): 88–94 (in Russ.). https://doi.org/10.17116/rosakush20202004188.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Debras E., Fernandez H., Neveu M.E., et al. Ovarian drilling in polycystic ovary syndrome: long term pregnancy rate. Eur J Obstet Gynecol Reprod Biol X. 2019; 4: 100093. https://doi.org/10.1016/j.eurox.2019.100093.</mixed-citation><mixed-citation xml:lang="en">Debras E., Fernandez H., Neveu M.E., et al. Ovarian drilling in polycystic ovary syndrome: long term pregnancy rate. Eur J Obstet Gynecol Reprod Biol X. 2019; 4: 100093. https://doi.org/10.1016/j.eurox.2019.100093.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Seow K.M., Chang Y.W., Chen K.H., et al. Molecular mechanisms of laparoscopic ovarian drilling and its therapeutic eﬀects in polycystic ovary syndrome. Int J Mol Sci. 2020; 21 (21): 8147. https://doi.org/10.3390/ijms21218147.</mixed-citation><mixed-citation xml:lang="en">Seow K.M., Chang Y.W., Chen K.H., et al. Molecular mechanisms of laparoscopic ovarian drilling and its therapeutic eﬀects in polycystic ovary syndrome. Int J Mol Sci. 2020; 21 (21): 8147. https://doi.org/10.3390/ijms21218147.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bordewijk E.M., Ng K.Y.B., Rakic L., et al. Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev. 2020; 2 (2): CD001122. https://doi.org/10.1002/14651858.CD001122.pub5.</mixed-citation><mixed-citation xml:lang="en">Bordewijk E.M., Ng K.Y.B., Rakic L., et al. Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev. 2020; 2 (2): CD001122. https://doi.org/10.1002/14651858.CD001122.pub5.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Попов А.А., Овчаренко Д.В., Коваль А.А. и др. Изменения гормонального профиля у пациенток с синдромом поликистозных яичников и бесплодием после хирургического лечения. Российский вестник акушера-гинеколога. 2020; 20 (4): 12–7. https://doi.org/10.17116/rosakush20202004112.</mixed-citation><mixed-citation xml:lang="en">Popov A.A., Ovcharenko D.V., Koval’ A.A., et al. Changes in the hormonal proﬁle in patients with polycystic ovary syndrome and infertility after surgical treatment. Russian Bulletin of Obstetrician-Gynecologist. 2020; 20 (4): 12–7 (in Russ.). https://doi.org/10.17116/rosakush20202004112.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Сулима А.Н., Баснаева А.Д. Программа «Fast track» в оперативной гинекологии. Российский вестник акушера-гинеколога. 2020; 20 (1): 81–6. https://doi.org/10.17116/rosakush20202001181.</mixed-citation><mixed-citation xml:lang="en">Sulima A.N., Basnaeva A.D. Fast track program in operative gynecology. Russian Bulletin of Obstetrician-Gynecologist. 2020; 20 (1): 81–6 (in Russ.). https://doi.org/10.17116/rosakush20202001181.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Кравченко Е.Н., Безнощенко Г.Б., Цыганкова О.Ю., Кропмаер К.П. Реабилитация после гинекологических операций в репродуктивном возрасте. Мать и дитя в Кузбассе. 2019; 3: 18–22.</mixed-citation><mixed-citation xml:lang="en">Kravchenko E.N., Beznoshchenko G.B., Tsygankova O.Yu., Kropmaer K.P. Rehabilitation after gynecological operations in reproductive age. Mother and Baby in Kuzbass. 2019; 3: 18–22 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ji C., Xu W., Zhang Z., et al. Eﬀect of electroacupuncture on reproductive disorders and insulin resistance in a murine polycystic ovary syndrome model. Evid Based Complement Alternat Med. 2021; 2021: 9968463. https://doi.org/10.1155/2021/9968463.</mixed-citation><mixed-citation xml:lang="en">Ji C., Xu W., Zhang Z., et al. Eﬀect of electroacupuncture on reproductive disorders and insulin resistance in a murine polycystic ovary syndrome model. Evid Based Complement Alternat Med. 2021; 2021: 9968463. https://doi.org/10.1155/2021/9968463.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Qu F., Li R., Sun W., et al. Use of electroacupuncture and transcutaneous electrical acupoint stimulation in reproductive medicine: a group consensus. J Zhejiang Univ Sci B. 2017; 18 (3): 186–93. https://doi.org/10.1631/jzus.B1600437.</mixed-citation><mixed-citation xml:lang="en">Qu F., Li R., Sun W., et al. Use of electroacupuncture and transcutaneous electrical acupoint stimulation in reproductive medicine: a group consensus. J Zhejiang Univ Sci B. 2017; 18 (3): 186–93. https://doi.org/10.1631/jzus.B1600437.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Коркан А.И., Туреханова А.Д., Тюгай Ю.Л. Современные методы лечения синдром поликистозных яичников (обзор литературы). Репродуктивная медицина. 2020; 1: 27–34. https://doi.org/10.37800/rm2020-1-5.</mixed-citation><mixed-citation xml:lang="en">Korkan A.I., Turekhanova A.D., Tyugay Y.L. Modern treatments for PCOS (literature review). Reproductive Medicine. 2020; 1: 27–34 (in Russ.). https://doi.org/10.37800/rm2020-1-5.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Бекмирзаева Ф.М., Шукуров Ф.И., Аюпова Ф.М. Оценка эффективности препарата Клостилбегит в индукции овуляции у женщин после эндохирургического лечения. Здоровье матери и ребенка. 2020; 2: 24–9.</mixed-citation><mixed-citation xml:lang="en">Bekmirzaeva F.M., Shukurov F.I., Ayupova F.M. Estimation of the eﬀectiveness of the clostilbegitis product in ovulation induction in women after endosurgical treatment. Maternal and Child Health Journal. 2020; 2: 24–9 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Abdelazim I.A. Letrozole following laparoscopic ovarian drilling in clomiphene resistant polycystic ovary syndrome women. West Kazakhstan Medical Journal. 2021; 63 (1): 4–10. https://doi.org/10.24412/2707-6180-2021-63-4-10.</mixed-citation><mixed-citation xml:lang="en">Abdelazim I.A. Letrozole following laparoscopic ovarian drilling in clomiphene resistant polycystic ovary syndrome women. West Kazakhstan Medical Journal. 2021; 63 (1): 4–10. https://doi.org/10.24412/2707-6180-2021-63-4-10.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Bahawi Y.O., Radwan E.M., Khouj M.A., et al. Pregnancy rates in women with polycystic ovary syndrome (PCOS) using letrozole versus clomiphene citrate: a retrospective record review. Cureus. 2023; 15 (7): e42257. https://doi.org/10.7759/cureus.42257.</mixed-citation><mixed-citation xml:lang="en">Bahawi Y.O., Radwan E.M., Khouj M.A., et al. Pregnancy rates in women with polycystic ovary syndrome (PCOS) using letrozole versus clomiphene citrate: a retrospective record review. Cureus. 2023; 15 (7): e42257. https://doi.org/10.7759/cureus.42257.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Bansal S., Goyal M., Sharma C., Shekhar S. Letrozole versus clomiphene citrate for ovulation induction in anovulatory women with polycystic ovarian syndrome: a randomized controlled trial. Int J Gynaecol Obstet. 2021; 152 (3): 345–50. https://doi.org/10.1002/ijgo.13375.</mixed-citation><mixed-citation xml:lang="en">Bansal S., Goyal M., Sharma C., Shekhar S. Letrozole versus clomiphene citrate for ovulation induction in anovulatory women with polycystic ovarian syndrome: a randomized controlled trial. Int J Gynaecol Obstet. 2021; 152 (3): 345–50. https://doi.org/10.1002/ijgo.13375.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu X., Fu Y. Extending letrozole treatment duration is eﬀective in inducing ovulation in women with polycystic ovary syndrome and letrozole resistance. Fertil Steril. 2023; 119 (1): 107–13. https://doi.org/10.1016/j.fertnstert.2022.09.018.</mixed-citation><mixed-citation xml:lang="en">Zhu X., Fu Y. Extending letrozole treatment duration is eﬀective in inducing ovulation in women with polycystic ovary syndrome and letrozole resistance. Fertil Steril. 2023; 119 (1): 107–13. https://doi.org/10.1016/j.fertnstert.2022.09.018.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Horowitz E., Weissman A. The stair-step approach in treatment of anovulatory PCOS patients. Ther Adv Reprod Health. 2020; 14: 2633494120908818. https://doi.org/10.1177/2633494120908818.</mixed-citation><mixed-citation xml:lang="en">Horowitz E., Weissman A. The stair-step approach in treatment of anovulatory PCOS patients. Ther Adv Reprod Health. 2020; 14: 2633494120908818. https://doi.org/10.1177/2633494120908818.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Сучек К.А., Фролова А.С., Петров Ю.А. Диагностика и лечение эндокринного бесплодия, ассоциированного с синдромом поликистозных яичников. Международный журнал прикладных и фундаментальных исследований. 2020; 1: 42–6.</mixed-citation><mixed-citation xml:lang="en">Suchek K.A., Frolova A.S., Petrov Yu.A. Diagnosis and treatment of endocrine infertility associated with polycystic ovary syndrome. International Journal of Applied and Fundamental Research. 2020; 1: 42–6 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Ших Е.В., Махова А.А., Гребенщикова Л.Ю., Багдасарян А.А. Микронутриентная поддержка репродуктивной при синдроме поликистозных яичников, осложненном метаболическими рисками. Вопросы гинекологии, акушерства и перинатологии. 2022; 21 (1): 108–15. https://doi.org/10.20953/1726-1678-2022-1-108-115.</mixed-citation><mixed-citation xml:lang="en">Shikh E.V., Makhova A.A., Grebenshchikova L.Yu., Bagdasaryan A.A. Micronutrient support among women of reproductive age with polycystic ovary syndrome complicated by metabolic risks. Gynecology, Obstetrics and Perinatology. 2022; 21 (1): 108–15 (in Russ.). https://doi.org/10.20953/1726-1678-2022-1-108-115.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Усеинова А.Н., Егорова Е.А., Елишева Е.А. и др. Основные направления и перспективы в терапии синдрома поликистоза яичников. Сибирский научный медицинский журнал. 2021; 41 (6): 18–29. https://doi.org/10.18699/ssmj20210602.</mixed-citation><mixed-citation xml:lang="en">Useinova A.N., Egorova E.A., Yelisheva E.A., et al. The main directions and prospects in polycystic ovary syndrome treatment. Siberian Scientiﬁc Medical Journal. 2021; 41 (6): 18–29 (in Russ.). https://doi.org/10.18699/ssmj20210602.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Sparić R., Andjić M., Rakić A., et al. Insulin-sensitizing agents for infertility treatment in woman with polycystic ovary syndrome: a narrative review of current clinical practice. Hormones. 2024; 23 (1): 49–58. https://doi.org/10.1007/s42000-023-00494-y.</mixed-citation><mixed-citation xml:lang="en">Sparić R., Andjić M., Rakić A., et al. Insulin-sensitizing agents for infertility treatment in woman with polycystic ovary syndrome: a narrative review of current clinical practice. Hormones. 2024; 23 (1): 49–58. https://doi.org/10.1007/s42000-023-00494-y.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Чернуха Г.Е., Пронина В.А. Коррекция метаболической дисфункции как метод восстановления функции репродуктивной системы у женщин. Медицинский совет. 2023; 17 (5): 90–7. https://doi.org/10.21518/ms2023-087.</mixed-citation><mixed-citation xml:lang="en">Chernukha G.E., Pronina V.A. Metabolic dysfunction correction as a method of restoring the function of the reproductive system in women. Meditsinskiy sovet / Medical Council. 2023; 17 (5): 90–7 (in Russ.). https://doi.org/10.21518/ms2023-087.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Fatima K., Jamil Z., Faheem S., et al. Eﬀects of myo-inositol vs. metformin on hormonal and metabolic parameters in women with PCOS: a meta-analysis. Ir J Med Sci. 2023; 192 (6): 2801–8. https://doi.org/10.1007/s11845-023-03388-5.</mixed-citation><mixed-citation xml:lang="en">Fatima K., Jamil Z., Faheem S., et al. Eﬀects of myo-inositol vs. metformin on hormonal and metabolic parameters in women with PCOS: a meta-analysis. Ir J Med Sci. 2023; 192 (6): 2801–8. https://doi.org/10.1007/s11845-023-03388-5.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Овчаренко Д.В., Попов А.А., Коваль А.А. и др. Влияние питательных веществ на метаболические нарушения, ассоциированные с синдромом поликистозных яичников. Российский вестник акушера-гинеколога. 2020; 20 (4): 27–33. https://doi.org/10.17116/rosakush20202004127.</mixed-citation><mixed-citation xml:lang="en">Ovcharenko D.V., Popov A.A., Koval’ A.A., et al. The eﬀect of nutrients on metabolic disorders associated with polycystic ovary syndrome. Russian Bulletin of Obstetrician-Gynecologist. 2020; 20 (4): 27–33 (in Russ.). https://doi.org/10.17116/rosakush20202004127.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Dinicola S., Unfer V., Facchinetti F., et al. Inositols: from established knowledge to novel approaches. Int J Mol Sci. 2021; 22 (19): 10575. https://doi.org/10.3390/ijms221910575.</mixed-citation><mixed-citation xml:lang="en">Dinicola S., Unfer V., Facchinetti F., et al. Inositols: from established knowledge to novel approaches. Int J Mol Sci. 2021; 22 (19): 10575. https://doi.org/10.3390/ijms221910575.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Санта-Мария Фернандес Д.О. Здоровый образ жизни как ведущая стратегия лечения пациенток с СПКЯ (обзор клинических рекомендаций). Женская клиника. 2022; 4: 42–56.</mixed-citation><mixed-citation xml:lang="en">Santa Maria Fernandez D.O. Healthy lifestyle as a leading strategy for the treatment of patients with PCOS (review of clinical recommendations). Women’s Clinic. 2022; 4: 42–56 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Greﬀ D., Juhasz A.E., Vancsa S., et al. Inositol is an eﬀective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Reprod Biol Endocrinol. 2023; 21 (1): 10. https://doi.org/10.1186/s12958-023-01055-z.</mixed-citation><mixed-citation xml:lang="en">Greﬀ D., Juhasz A.E., Vancsa S., et al. Inositol is an eﬀective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Reprod Biol Endocrinol. 2023; 21 (1): 10. https://doi.org/10.1186/s12958-023-01055-z.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Прилуцкая В.Ю., Аляутдина О.С., Сосна Н.А. Влияние комбинации миоинозитола и D-хироинозитола в соотношении 5:1 на психоэмоциональное состояние и проявления андрогензависимой дермопатии у пациенток с синдромом поликистозных яичников. Проблемы репродукции. 2021; 27 (4): 97–107. https://doi.org/10.17116/repro20212704197.</mixed-citation><mixed-citation xml:lang="en">Prilutskaya V.Yu., Alyautdina O.S., Sosna N.A. The eﬀect of the combination of myoinositol and D-chiroinositol in a ratio of 5:1 on the psychoemotional state and manifestations of androgen-dependent dermopathy in patients with polycystic ovary syndrome. Russian Journal of Human Reproduction. 2021; 27 (4): 97–107 (in Russ.). https://doi.org/10.17116/repro20212704197.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Цатурова К.А., Вартанян Э.В., Девятова Е.А. Преконцепционная терапия при бесплодии, ассоциированном с синдромом поликистозных яичников. Актуальные вопросы женского здоровья. 2022; 1: 14–9. https://doi.org/10.46393/2713122X_2022_1_14.</mixed-citation><mixed-citation xml:lang="en">Tsaturova K.A., Vartanyan E.M., Devyatova E.A. Preconception approach for polycystic ovary syndrome-associated infertility. Actual Issues of Women's Health. 2022; 1: 14–9 (in Russ.). https://doi.org/10.46393/2713122X_2022_1_14.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Rizk M.G., Thackray V.G. Intersection of polycystic ovary syndrome and the gut microbiome. J Endocr Soc. 2020; 5 (2): bvaa177. https://doi.org/10.1210/jendso/bvaa177.</mixed-citation><mixed-citation xml:lang="en">Rizk M.G., Thackray V.G. Intersection of polycystic ovary syndrome and the gut microbiome. J Endocr Soc. 2020; 5 (2): bvaa177. https://doi.org/10.1210/jendso/bvaa177.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Толстова А.С., Морозов М.В., Родин О.В. и др. Синдромом поликистозных яичников и их взаимосвязь с микробиотой кишечника и влагалища (oбзор литературы). Современная наука: актуальные проблемы теории и практики. Серия: Естественные и технические науки. 2021; 5: 206–14. https://doi.org/10.37882/2223-2966.2021.05.29.</mixed-citation><mixed-citation xml:lang="en">Tolstova A.S., Morozov M.V., Rodin O.V., et al. Polycystic ovary syndrome and their relationship with gut and vaginal microbiota (literature review). Modern Science: Actual Problems of Theory and Practice. Series: Natural and Technical Sciences. 2021; 5: 206–14 (in Russ.). https://doi.org/10.37882/2223-2966.2021.05.29.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Ших Е.В., Махова А.А., Шаронова С.С. Пероральные пробиотики в женском здоровье: экспериментальные данные и результаты клинических исследований. Вопросы гинекологии, акушерства и перинатологии. 2021; 20 (2): 102–9. https://doi.org/10.20953/1726-1678-2021-2-102-109.</mixed-citation><mixed-citation xml:lang="en">Shikh E.V., Makhova A.A., Sharonova S.S. Oral probiotics in women's health: experimental evidence and results from clinical trials. Gynecology, Obstetrics and Perinatology. 2021; 20 (2): 102–9 (in Russ.). https://doi.org/10.20953/1726-1678-2021-2-102-109.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Самбялова А.Ю. Молекулярные механизмы функционирования эндометрия у женщин с синдромом поликистозных яичников. Acta Biomedica Scientiﬁca. 2020; 5 (6): 9–19. https://doi.org/10.29413/ABS.2020-5.6.1.</mixed-citation><mixed-citation xml:lang="en">Sambyalova A.Yu. Molecular mechanisms of endometrial functioning in women with polycystic ovary syndrome. Acta Biomedica Scientiﬁca. 2020; 5 (6): 9–19 (in Russ.). https://doi.org/10.29413/ABS.2020-5.6.1.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Зайдиева З.С., Уруймагова А.Т. Синдром поликистозных яичников: современные представления патогенеза, диагностики и лечения. Медицинский совет. 2021; 13: 102–11. https://doi.org/10.21518/2079-701x-2021-13-102-111.</mixed-citation><mixed-citation xml:lang="en">Zaydiyeva Z.S., Uruymagova A.T. Polycystic ovarian syndrome: current understanding of pathogenesis, diagnosis and treatment. Meditsinskiy sovet / Medical Council. 2021; 13: 102–11 (in Russ.). https://doi.org/10.21518/2079-701x-2021-13-102-111.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Соколова Е.А., Краснопольская К.В., Белокурова М.В., Исакова К.М. Состояние эндометрия у пациенток с синдромом поликистозных яичников. Российский вестник акушера-гинеколога. 2021; 21 (2): 86–90. https://doi.org/10.17116/rosakush20212102186.</mixed-citation><mixed-citation xml:lang="en">Sokolova E.A., Krasnopol’skaya K.V., Belokurova M.V., Isakova K.M. Endometrial condition in patients with polycystic ovary syndrome. Russian Bulletin of Obstetrician-Gynecologist. 2021; 21 (2): 86–90 (in Russ.). https://doi.org/10.17116/rosakush20212102186.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Жабченко И.А., Сюдмак О.Р. Особенности фертильности у женщин старшего репродуктивного возраста: проблемы отложенного деторождения и методы их коррекции. Репродуктивная медицина. 2019; 3: 29–36.</mixed-citation><mixed-citation xml:lang="en">Zhabchenko I.А., Suіdmak О.R. Features of fecundity for women of senior reproductive age: Problems of the set aside procreation and methods of their correction. Reproductive Medicine. 2019; 3: 29–36 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Шукуров Ф.И., Мамажанова Д.М., Юлдашева Н.З., Саттарова К.А. Оценка эффективности применения препарата «Белара» в адъювантной терапии синдрома поликистозных яичников после эндохирургического лечения. Экспериментальная и клиническая фармакология. 2022; 85 (8): 14–6. https://doi.org/10.30906/0869-2092-2022-85-8-14-16.</mixed-citation><mixed-citation xml:lang="en">Shukurov F.I., Mamadzhanova D.M., Yuldasheva N.Z., Sattarova K.A. Estimation of the eﬃciency of Belara application in adjuvant therapy of polycystic ovarian syndrome after endosurgical treatment. Experimental and Clinical Pharmacology. 2022; 85 (8): 14–6 (in Russ.). https://doi.org/10.30906/0869-2092-2022-85-8-14-16.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Шукуров Ф.И., Аюпова Ф.М., Бекмирзаева Ф.М. Применение Белара в сочетании с Лонгидаза в реабилитации репродуктивной функции у женщин, после эндохирургического лечения синдрома поликистозных яичников. Здоровье матери и ребенка. 2020; 2: 38–43.</mixed-citation><mixed-citation xml:lang="en">Shukurov F.I., Ayupova F.M., Bekmirzaeva F.M. The use of Belara in combination with Longidaza in the rehabilitation of reproductive function in women after endosurgical treatment of polycystic ovary syndrome. Maternal and Child Health Journal. 2020; 2: 38–43.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Шумейкина А.О. Хронический эндометрит (ХЭ) как наиболее частая болезнь эндометрия при синдроме поликистозных яичников (СПКЯ). Тезисы III Общероссийской научнопрактической конференции для акушеров-гинекологов «Оттовские чтения», Санкт-Петербург, 12–13 ноября 2021 г. М.: StatusPraesens; 2021: 80–1.</mixed-citation><mixed-citation xml:lang="en">Shumeikina A.O. Chronic endometritis (CE) as the most common endometrial disease in polycystic ovary syndrome (PCOS). Abstracts of the III All-Russian Scientiﬁc and Practical Conference for Obstetricians and Gynecologists “Otto Readings”, St. Petersburg, November 12–13, 2021. Мoscow: StatusPraesens; 2021: 80–1 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Ильина И.Ю. Особенности лечения пациенток с синдромом поликистозных яичников и метаболическим синдромом. Русский медицинский журнал. Мать и дитя. 2020; 3 (4): 254–9. https://doi.org/10.32364/2618-8430-2020-3-4-254-259.</mixed-citation><mixed-citation xml:lang="en">Il’ina I.Yu. Speciﬁcities of the treatment for polycystic ovary syndrome and metabolic syndrome. Russian Journal of Woman and Child Health. 2020; 3 (4): 254–9 (in Russ.). https://doi.org/10.32364/2618-8430-2020-3-4-254-259.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Talebi S., Shab-Bidar S., Mohammadi H., et al. The eﬀects of intermittent fasting diet alone or in combination with probiotic supplementation in comparison with calorie-restricted diet on metabolic and hormonal proﬁle in patients with polycystic ovary syndrome: study protocol for a randomized clinical trial. Trials. 2023; 24 (1): 690. https://doi.org/10.1186/s13063-023-07691-5.</mixed-citation><mixed-citation xml:lang="en">Talebi S., Shab-Bidar S., Mohammadi H., et al. The eﬀects of intermittent fasting diet alone or in combination with probiotic supplementation in comparison with calorie-restricted diet on metabolic and hormonal proﬁle in patients with polycystic ovary syndrome: study protocol for a randomized clinical trial. Trials. 2023; 24 (1): 690. https://doi.org/10.1186/s13063-023-07691-5.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Елисеева Т., Ткачева Н. DASH-диета – научное обоснование, доказанная польза для здоровья, преимущества и недостатки. Журнал здорового питания и диетологии. 2020; 1 (11): 90–9. https://doi.org/10.59316/.vi11.69.</mixed-citation><mixed-citation xml:lang="en">Eliseeva T., Tkacheva N. DASH-diet – scientiﬁc justiﬁcation, proven health beneﬁts, advantages and disadvantages. Journal of Healthy Nutrition and Dietetics. 2020; 1 (11): 90–9 (in Russ.). https://doi.org/10.59316/.vi11.69.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Paoli A., Mancin L., Giacona M.C., et al. Eﬀects of a ketogenic diet in overweight women with polycystic ovary syndrome. J Transl Med. 2020; 18 (1): 104. https://doi.org/10.1186/s12967-020-02277-0.</mixed-citation><mixed-citation xml:lang="en">Paoli A., Mancin L., Giacona M.C., et al. Eﬀects of a ketogenic diet in overweight women with polycystic ovary syndrome. J Transl Med. 2020; 18 (1): 104. https://doi.org/10.1186/s12967-020-02277-0.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Kazemi M., Hadi A., Pierson R.A., et al. Eﬀects of dietary glycemic index and glycemic load on cardiometabolic and reproductive proﬁles in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Adv Nutr. 2021; 12 (1): 161–78. https://doi.org/10.1093/advances/nmaa092.</mixed-citation><mixed-citation xml:lang="en">Kazemi M., Hadi A., Pierson R.A., et al. Eﬀects of dietary glycemic index and glycemic load on cardiometabolic and reproductive proﬁles in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Adv Nutr. 2021; 12 (1): 161–78. https://doi.org/10.1093/advances/nmaa092.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Szmidt M.K., Granda D., Madej D., et al. Adherence to the Mediterranean diet in women and reproductive health across the lifespan: a narrative review. Nutrients. 2023; 15 (9): 2131. https://doi.org/10.3390/nu15092131.</mixed-citation><mixed-citation xml:lang="en">Szmidt M.K., Granda D., Madej D., et al. Adherence to the Mediterranean diet in women and reproductive health across the lifespan: a narrative review. Nutrients. 2023; 15 (9): 2131. https://doi.org/10.3390/nu15092131.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Shang Y., Zhou H., He R., Lu W. Dietary modiﬁcation for reproductive health in women with polycystic ovary syndrome: a systematic review and meta-analysis. Front Endocrinol. 2021; 12: 735954. https://doi.org/10.3389/fendo.2021.735954.</mixed-citation><mixed-citation xml:lang="en">Shang Y., Zhou H., He R., Lu W. Dietary modiﬁcation for reproductive health in women with polycystic ovary syndrome: a systematic review and meta-analysis. Front Endocrinol. 2021; 12: 735954. https://doi.org/10.3389/fendo.2021.735954.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Patten R.K., McIlvenna L.C., Moreno-Asso A., et al. Eﬃcacy of high-intensity interval training for improving mental health and health-related quality of life in women with polycystic ovary syndrome. Sci Rep. 2023; 13 (1): 3025. https://doi.org/10.1038/s41598-023-29503-1.</mixed-citation><mixed-citation xml:lang="en">Patten R.K., McIlvenna L.C., Moreno-Asso A., et al. Eﬃcacy of high-intensity interval training for improving mental health and health-related quality of life in women with polycystic ovary syndrome. Sci Rep. 2023; 13 (1): 3025. https://doi.org/10.1038/s41598-023-29503-1.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Олина А.А., Метелева Т.А., Пирожникова Н.М. Синдром поликистозных яичников и репродуктивное поведение современной молодежи. Русский медицинский журнал. Мать и дитя. 2020; 3 (1): 3–8. https://doi.org/10.32364/2618-8430-2020-3-1-3-8.</mixed-citation><mixed-citation xml:lang="en">Olina A.A., Meteleva T.A., Pirozhnikova N.M. Polycystic ovary syndrome and reproductive behavior of today’s youth. Russian Journal of Woman and Child Health. 2020; 3 (1): 3–8 (in Russ.). https://doi.org/10.32364/2618-8430-2020-3-1-3-8.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Mohammadi S., Monazzami A., Alavimilani S. Eﬀects of eight-week high-intensity interval training on some metabolic, hormonal and cardiovascular indices in women with PCOS: a randomized controlled trail. BMC Sports Sci Med Rehabil. 2023; 15 (1): 47. https://doi.org/10.1186/s13102-023-00653-z.</mixed-citation><mixed-citation xml:lang="en">Mohammadi S., Monazzami A., Alavimilani S. Eﬀects of eight-week high-intensity interval training on some metabolic, hormonal and cardiovascular indices in women with PCOS: a randomized controlled trail. BMC Sports Sci Med Rehabil. 2023; 15 (1): 47. https://doi.org/10.1186/s13102-023-00653-z.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Patten R.K., McIlvenna L.C., Levinger I., et al. High-intensity training elicits greater improvements in cardio-metabolic and reproductive outcomes than moderate-intensity training in women with polycystic ovary syndrome: a randomized clinical trial. Hum Reprod. 2022; 37 (5): 1018–29. https://doi.org/10.1093/humrep/deac047.</mixed-citation><mixed-citation xml:lang="en">Patten R.K., McIlvenna L.C., Levinger I., et al. High-intensity training elicits greater improvements in cardio-metabolic and reproductive outcomes than moderate-intensity training in women with polycystic ovary syndrome: a randomized clinical trial. Hum Reprod. 2022; 37 (5): 1018–29. https://doi.org/10.1093/humrep/deac047.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Abdulkhalikova D., Sustarsic A., Vrtačnik Bokal E., et al. The lifestyle modiﬁcations and endometrial proteome changes of women with polycystic ovary syndrome and obesity. Front Endocrinol. 2022; 13: 888460. https://doi.org/10.3389/fendo.2022.888460.</mixed-citation><mixed-citation xml:lang="en">Abdulkhalikova D., Sustarsic A., Vrtačnik Bokal E., et al. The lifestyle modiﬁcations and endometrial proteome changes of women with polycystic ovary syndrome and obesity. Front Endocrinol. 2022; 13: 888460. https://doi.org/10.3389/fendo.2022.888460.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao J., Dong L., Lin Z., et al. Eﬀects of selenium supplementation on polycystic ovarian syndrome: a systematic review and meta-analysis on randomized clinical trials. BMC Endocr Disord. 2023; 23 (1): 33. https://doi.org/10.1186/s12902-023-01286-6.</mixed-citation><mixed-citation xml:lang="en">Zhao J., Dong L., Lin Z., et al. Eﬀects of selenium supplementation on polycystic ovarian syndrome: a systematic review and meta-analysis on randomized clinical trials. BMC Endocr Disord. 2023; 23 (1): 33. https://doi.org/10.1186/s12902-023-01286-6.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Abdallah A.B.E., El-Ghannam M.A., Hasan A.A., et al. Selenium nanoparticles modulate steroidogenesis-related genes and improve ovarian functions via regulating androgen receptors expression in polycystic ovary syndrome rat model. Biol Trace Elem Res. 2023; 201 (12): 5721–33. https://doi.org/10.1007/s12011-023-03616-0.</mixed-citation><mixed-citation xml:lang="en">Abdallah A.B.E., El-Ghannam M.A., Hasan A.A., et al. Selenium nanoparticles modulate steroidogenesis-related genes and improve ovarian functions via regulating androgen receptors expression in polycystic ovary syndrome rat model. Biol Trace Elem Res. 2023; 201 (12): 5721–33. https://doi.org/10.1007/s12011-023-03616-0.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Li R., Li Z., Huang Y., et al. The eﬀect of magnesium alone or its combination with other supplements on the markers of inﬂammation, OS and metabolism in women with polycystic ovarian syndrome (PCOS): a systematic review. Front Endocrinol. 2022; 13: 974042. https://doi.org/10.3389/fendo.2022.974042.</mixed-citation><mixed-citation xml:lang="en">Li R., Li Z., Huang Y., et al. The eﬀect of magnesium alone or its combination with other supplements on the markers of inﬂammation, OS and metabolism in women with polycystic ovarian syndrome (PCOS): a systematic review. Front Endocrinol. 2022; 13: 974042. https://doi.org/10.3389/fendo.2022.974042.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Иванова Л.А., Король И.В., Коваленко Ю.С. и др. Применение тиоктовой кислоты у женщин с синдромом поликистозных яичников и нормальной массой тела. Международный журнал гуманитарных и естественных наук. 2022; 10-1: 90–6. https://doi.org/10.24412/2500-1000-2022-10-1-90-96.</mixed-citation><mixed-citation xml:lang="en">Ivanova L.A., Korol’ I.V., Kovalenko Yu.S., et al. Application of thioctic acid in women with polycystic ovary syndrome and normal body mass. International Journal of Humanities and Natural Sciences. 2022; 10-1: 90–6 (in Russ.). https://doi.org/10.24412/2500-1000-2022-10-1-90-96.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Гутикова Л.В. Клинические эффекты альфа-липоевой кислоты для здоровья женщин. Репродуктивное здоровье. Восточная Европа. 2021; 11 (3): 371–81. https://doi.org/10.34883/PI.2021.11.3.009.</mixed-citation><mixed-citation xml:lang="en">Gutikova L.V. Clinical eﬀects of alpha-lipoic acid for women's health. Reproductive Health. Eastern Europe. 2021; 11 (3): 371–81 (in Russ.). https://doi.org/10.34883/PI.2021.11.3.009.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Патий Е.В., Беттихер О.А., Горелова И.В. и др. Патогенетическое обоснование применения витамина D при синдроме поликистозных яичников. Женское здоровье и репродукция. 2023; 1: 85–97.</mixed-citation><mixed-citation xml:lang="en">Patiy E.V., Bettikher O.A., Gorelova I.V. et al. Pathogenetic rationale for the use of vitamin D in PCOS. Women's Health and Reproduction. 2023; 1: 85–97 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Yang M., Shen X., Lu D., et al. Eﬀects of vitamin D supplementation on ovulation and pregnancy in women with polycystic ovary syndrome: a systematic review and meta-analysis. Front Endocrinol. 2023; 14: 1148556. https://doi.org/10.3389/fendo.2023.1148556.</mixed-citation><mixed-citation xml:lang="en">Yang M., Shen X., Lu D., et al. Eﬀects of vitamin D supplementation on ovulation and pregnancy in women with polycystic ovary syndrome: a systematic review and meta-analysis. Front Endocrinol. 2023; 14: 1148556. https://doi.org/10.3389/fendo.2023.1148556.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Артымук Н.В., Тачкова О.А. Новое о патогенезе и лечении синдрома поликистозных яичников. Русский медицинский журнал. Мать и дитя. 2021; 4 (1): 17–22. https://doi.org/10.32364/2618-8430-2021-4-1-17-22.</mixed-citation><mixed-citation xml:lang="en">Artymuk N.V., Tachkova O.A. New about the pathogenesis and treatment of polycystic ovary syndrome. Russian Journal of Woman and Child Health. 2021; 4 (1): 17–22 (in Russ.). https://doi.org/10.32364/2618-8430-2021-4-1-17-22.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Xu Y., Tang J., Guo Q., et al. Traditional Chinese Medicine formula FTZ protects against polycystic ovary syndrome through modulating adiponectin-mediated fat-ovary crosstalk in mice. J Ethnopharmacol. 2021; 268: 113587. https://doi.org/10.1016/j.jep.2020.113587.</mixed-citation><mixed-citation xml:lang="en">Xu Y., Tang J., Guo Q., et al. Traditional Chinese Medicine formula FTZ protects against polycystic ovary syndrome through modulating adiponectin-mediated fat-ovary crosstalk in mice. J Ethnopharmacol. 2021; 268: 113587. https://doi.org/10.1016/j.jep.2020.113587.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Heshmati J., Sepidarkish M., Morvaridzadeh M., et al. The eﬀect of cinnamon supplementation on glycemic control in women with polycystic ovary syndrome: a systematic review and meta-analysis. J Food Biochem. 2021; 45 (1): e13543. https://doi.org/10.1111/jfbc.13543.</mixed-citation><mixed-citation xml:lang="en">Heshmati J., Sepidarkish M., Morvaridzadeh M., et al. The eﬀect of cinnamon supplementation on glycemic control in women with polycystic ovary syndrome: a systematic review and meta-analysis. J Food Biochem. 2021; 45 (1): e13543. https://doi.org/10.1111/jfbc.13543.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Allahbadia G.N. Primum non nocere. J Obstet Gynaecol India. 2016; 66 (2): 71–5. https://doi.org/10.1007/s13224-015-0799-1.</mixed-citation><mixed-citation xml:lang="en">Allahbadia G.N. Primum non nocere. J Obstet Gynaecol India. 2016; 66 (2): 71–5. https://doi.org/10.1007/s13224-015-0799-1.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Mercorio A., Della Corte L., De Angelis M.C., et al. Ovarian drilling: back to the future. Medicina. 2022; 58 (8): 1002. https://doi.org/10.3390/medicina58081002.</mixed-citation><mixed-citation xml:lang="en">Mercorio A., Della Corte L., De Angelis M.C., et al. Ovarian drilling: back to the future. Medicina. 2022; 58 (8): 1002. https://doi.org/10.3390/medicina58081002.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Доброхотова Ю.Э., Хрянин А.А., Ших Е.В. и др. Совет экспертов: перспективные направления системной энзимотерапии в гинекологии. Русский медицинский журнал. Мать и дитя. 2023; 6 (2): 149–56. https://doi.org/10.32364/2618-8430-2023-6-2-149-156.</mixed-citation><mixed-citation xml:lang="en">Dobrokhotova Yu.E., Khryanin A.A., Shikh E.V., et al. Expert Council: promising areas of systemic enzyme therapy in gynecology. Russian Journal of Woman and Child Health. 2023; 6 (2): 149–56 (in Russ.). https://doi.org/10.32364/2618-8430-2023-6-2-149-156.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Amer S.A., Shamy T.T.E., James C., et al. The impact of laparoscopic ovarian drilling on AMH and ovarian reserve: a meta-analysis. Reproduction. 2017; 154 (1): R13–21. https://doi.org/10.1530/REP-17-0063.</mixed-citation><mixed-citation xml:lang="en">Amer S.A., Shamy T.T.E., James C., et al. The impact of laparoscopic ovarian drilling on AMH and ovarian reserve: a meta-analysis. Reproduction. 2017; 154 (1): R13–21. https://doi.org/10.1530/REP-17-0063.</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Hussaini T.K., Zakhera M.S., Abdel-Aleem M., Abbas A.M. Premature ovarian failure/dysfunction following surgical treatment of polycystic ovarian syndrome: a case series. Middle East Fertil Soc J. 2017; 22: 233–5. https://doi.org/10.1016/j.mefs.2017.03.008.</mixed-citation><mixed-citation xml:lang="en">Hussaini T.K., Zakhera M.S., Abdel-Aleem M., Abbas A.M. Premature ovarian failure/dysfunction following surgical treatment of polycystic ovarian syndrome: a case series. Middle East Fertil Soc J. 2017; 22: 233–5. https://doi.org/10.1016/j.mefs.2017.03.008.</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Блинов Д.В., Хазан П.Л., Мнацаканьян А.Н. и др. Ранняя менопауза и преждевременная недостаточность яичников: проблемы и перспективы. Акушерство, гинекология и репродукция. 2020; 14 (3): 328–45. https://doi.org/10.17749/2313-7347/ob.gyn.rep.2020.173.</mixed-citation><mixed-citation xml:lang="en">Blinov D.V., Hasan P.L., Mnatsakanyan A.N., et al. Early menopause and premature ovarian insuﬃciency: problems and perspectives. Obstetrics, Gynecology and Reproduction. 2020; 14 (3): 328–45 (in Russ.). https://doi.org/10.17749/2313-7347/ob.gyn.rep.2020.173.</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Аверкова В.Г., Донников А.Е. Преждевременная недостаточность яичников: последствия для здоровья и стратегии заместительной гормональной терапии. Доктор.Ру. 2023; 22 (5): 49–53. https://doi.org/10.31550/1727-2378-2023-22-5-49-53.</mixed-citation><mixed-citation xml:lang="en">Averkova V.G., Donnikov A.E. Premature ovarian insuﬃciency: long-term health consequences and hormone replacement therapy strategies. Doctor.Ru. 2023; 22 (5): 49–53 (in Russ.). https://doi.org/10.31550/1727-2378-2023-22-5-49-53.</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Зайдиева Я.З., Казанцева В.Д. Синдром поликистозных яичников у женщин среднего возраста: заболевания, ассоциированные с ним. Российский вестник акушера-гинеколога. 2022; 22 (1): 45–51. https://doi.org/10.17116/rosakush20222201145.</mixed-citation><mixed-citation xml:lang="en">Zaidieva Ya.Z., Kazantseva V.D. Polycystic ovary syndrome in middle-aged women: associated diseases. Russian Bulletin of Obstetrician-Gynecologist. 2022; 22 (1): 45–51 (in Russ.). https://doi.org/10.17116/rosakush20222201145.</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Ильина Н.А., Бобров А.Е., Довженко Т.В., Гродницкая Е.Э. Психические расстройства и личностные особенности у пациенток с синдромом поликистозных яичников. Журнал неврологии и психиатрии им. С.С. Корсакова. 2022; 122 (4): 87–93. https://doi.org/10.17116/jnevro202212204187.</mixed-citation><mixed-citation xml:lang="en">Ilyina N.A., Bobrov A.E., Dovzhenko T.V., Grodnitskaya E.E. Mental disorders and personality characteristics of patients with polycystic ovary syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2022; 122 (4): 87–93 (in Russ.). https://doi.org/10.17116/jnevro202212204187.</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Лазарева Л.М., Шарифулин Э.М., Беленькая Л.В., Сутурина Л.В. СПКЯ в репродуктивном возрасте: фенотипическое разнообразие и диагностические подходы (обзор литературы). Доктор.Ру. 2020; 19 (6): 50–6. https://doi.org/10.31550/1727-2378-2020-19-6-50-56.</mixed-citation><mixed-citation xml:lang="en">Lazareva L.M., Sharifulin E.M., Belenkaya L.V., Suturina L.V. Polycystic ovary syndrome in women of reproductive age: phenotypic variety and diagnostic approaches. Review of literature. Doctor.Ru. 2020; 19 (6): 50–6 (in Russ.). https://doi.org/10.31550/1727-2378-2020-19-6-50-56.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
